Drugs / Tyroserleutide
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03516448 Comparator | Mar → Jun 2016 | hepatocellular carcinoma | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
| Phase 3 | NCT01489566 Comparator | Jul 2011 → Mar 2013 | hepatocellular carcinoma | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tyroserleutide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03516448 ↗ |
| Route | Intravenous | “6mg/d, 5days,ivgtt” NCT03516448 ↗ |